It could also be demonstrated that C-188-9, a small molecule STAT3 inhibitor that targets the Tyr705 peptide binding pocket, decreased FMD induced by TGF-β in cultured lung fibroblasts as well as significantly reduced experimental pulmonary fibrosis in mice [69]. Here, TGFB1 is linked to pulmonary fibrosis.